HR 1720 United States House · 117th Congress

COVID–19 Medical Production Act

Summary
COVID-19 Medical Production Act This bill provides additional funding for FY2021 to acquire medical supplies, vaccines, and other equipment to combat COVID-19 (i.e., coronavirus disease 2019) using authorities under the Defense Production Act of 1950. That act confers on the President a broad set of authorities to influence domestic industry to provide essential materials and goods for the national defense. This funding is available through FY2025. Beginning in FY2023, it may be used to meet public health needs to address any pathogen determined by the President to have the potential to create a public health emergency.
Bill status in committee 1 of 4 stages cleared
Introduction
Mar 2021
Committee Review
Floor Vote
President
Introduced Mar 9, 2021 Last action Mar 9, 2021
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
2
Key actions
0
Committee
1
Mar 9, 2021
Committee
Referred to the House Committee on Financial Services.
lower
Mar 9, 2021
Introduced
Introduced in House
lower
1 primary · 1 co-sponsor

Sponsors